Advertisement

Risks and Benefits of Immunological Contraception

  • R. John Aitken
  • Margaret Paterson
  • P. Thillai Koothan
Part of the Schering Foundation Workshop book series (SCHERING FOUND, volume 4)

Abstract

We now stand at the beginning of a decade when we expect the global population to rise by around 500 million. This increase will mean that the world will have to house, clothe and feed an additional population the size of China’s. Moreover, because the rates of population growth in the developing countries of Africa, South America and Asia are so much higher than in the rest of the world, the distribution of this dramatic population growth will be uneven. The result of this inbalance will be that by the year 2000 approximately 80% of the world’s population will be living in developing countries. When this pattern of population growth is translated into terms of environmental destruction, famine and disease, it is clear that whatever methods of contraception are developed for the future, they must take into account the needs of developing countries.

Keywords

Zona Pellucida Acrosome Reaction Primordial Follicle Contraceptive Vaccine Sperm Surface 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aitken RJ, Hulme MJ, Henderson CJ, Hargreave TB, Ross A (1987) Analysis of the surface labelling characeriatics of human spermatozoa and the interaction with anti-sperm antibodies. J Reprod Fertil 80: 473–485PubMedCrossRefGoogle Scholar
  2. Aitken RJ, Paterson M, Braude P., Thillai Koothan P (1990) Evaluation of glycosylated and deglycosylated porcine zona antigens for contraceptive efficacy in vivo and in vitro. In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 293Google Scholar
  3. Chamberlin ME, Dean J (1989) Genomic organization of a sex specific gene: the primary sperm receptor of the mouse zona pellucida. Dev Biol 131: 207–214PubMedCrossRefGoogle Scholar
  4. Chamberlin ME, Dean J (1990) Characterization of a gene unique to mammals: zona pellucida 3. Proc Natl. Acad Sci USA 87: 6014–6018PubMedCrossRefGoogle Scholar
  5. DeIoannes AE, Becker MI, Perez C, Capote C, Banos C (1990) Role of acrosin and antibodies to acrosin in gamete interactions.In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 185Google Scholar
  6. Gaur A, Arunan K, Singh O, Talwar GP (1990) Bypass by an alternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int Immunol 2: 151–155PubMedCrossRefGoogle Scholar
  7. Gulyas BJ. Gwatkin RBL, Yuan LC (1983) Active immunization of cynomolgus monkeys ( Macaca fascicularis) with porcine zonae pellucidae. Gamete Res: 299–307Google Scholar
  8. Henderson CJ, Hulme MJ, AitkenRJ (1988) Contraceptive potential of antibodies to the zona pellucida. J Reprod Fertil 83: 325–343Google Scholar
  9. Herr JC, Wright RM, John E, Klotz K, Homyk M, Foster J, Flickinger CJ (1990) Monoclonal antibody MHS-10 and its cognate intra-acrosomal antigen SP10. In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 13Google Scholar
  10. Hingorani V, Kumar S (1979) Anti-hCG immunization - Phase 1 clinical trials. In: Talwar G P (ed) Recent advances in reproduction and regulation of fertility. Elsevier, Amsterdam, p 467Google Scholar
  11. Jones WR, Bradley SJ, Judd SJ, Denholm EH, Ing RMY, Mueller UW, Powell JE, Griffin PD, Stevens VC (1988) Phase 1 clinical trial of a World Health Organization birth control vaccine. Lancet 1: 1295–1298PubMedCrossRefGoogle Scholar
  12. Keenan JA, Sacco AG, Subramanian MG, Kruger M,Yurewicz EC, Moghissi KS (1991) Endocrine response in rabbits immunized with native versus deglycosylated porcine zona pellucida. Biol Reprod 44: 150–156Google Scholar
  13. Kumar S, Sharma NC, Bajaj JS, Talwar GP, Hingorani V (1976) Clinical profile toxicology studies on four women immunized with Pr-13-hCG,-TT. Contraception 13: 252–267CrossRefGoogle Scholar
  14. Lee C-YG, Lum V, Wong E, Menge AC, Huang Y-S (1983) Identification of human sperm antigens to antisperm antibodies. Am J Reprod Immunol 3: 183–187PubMedGoogle Scholar
  15. Lee C-Y G, Liu M-S, Su M-W, Zhu J-B (1990) Studies of sperm antigens reactive to HS-11 and HS-63 monoclonal antibodies. In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 37Google Scholar
  16. Leyton L, Saling P (1989) 95 kD sperm proteins bind ZP3 and serve as tyro- sine kinase substrates in response to zona binding. Cell 57: 1123–1130PubMedCrossRefGoogle Scholar
  17. Millar SE, Chamow SM, Baur AW, Oliver C, Robey F, Dean J (1989) Vaccination with a synthetic zona pellucida peptide produces long term contraception in female mice. Science 246: 935–938PubMedCrossRefGoogle Scholar
  18. Mitchison N A (1990) Gonadotrophin vaccines. Curr Opin Immunol 2: 725–727CrossRefGoogle Scholar
  19. Moore HDM, Hartman TD, Bye AP, Lutjen P, De Witt M, Trounson AO (1987) Monoclonal antibodies against a sperm antigen Mr.95,000 inhibits attachment of human spermatozoa to the zona pellucida. J Reprod Immunol 11: 157–166PubMedCrossRefGoogle Scholar
  20. Morton DB, McAnulty PA (1979) The effect on fertility of immunizing female sheep with ram sperm acrosin and hyaluronidase. J Reprod Immunol 1: 61–73PubMedCrossRefGoogle Scholar
  21. Nash H, Talwar GP, Segal S, Luukkainen T, Johannsson EDB, Vasquez J, Coutino E, Sundaram K (1980) Observations on the antigenicity and clinical effects of a candidate anti-fertility vaccine: 13-subunit of human chorionic gonadotrophin linked to tetanus toxoid. Fertil Steril. 34: 328–335PubMedGoogle Scholar
  22. Naz RK, Ahmed K, Kumar R (1991) Role of membrane phosphotyrosine proteins in human spermatozoal function. J Cell Science 99: 157–165PubMedGoogle Scholar
  23. Paterson M, Thillai Koothan P, Morris K, O’Byrne KT, Braude P, Williams A, Aitken RJ (1992) Analysis of the contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and in vitro. Biol Reprod (in press)Google Scholar
  24. Primakoff P, Hyatt H, Myles DG (1985) A role for the migrating antigen PH-20 in guinea pig sperm binding to the egg zona pellucida. J Cell Biol 101: 2239–2244PubMedCrossRefGoogle Scholar
  25. Primakoff P, Lanthrop W, Woolman L, Cowan A, Myles DG (1988) Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature 335: 543–546PubMedCrossRefGoogle Scholar
  26. Rose NR, Burek CL, Smith JP (1988) Safety evaluation of hCG vaccine in primates: autoantibody production. In: Talwar GP (ed) Contraception research for today and the nineties. New York, Springer Verlag pp 231–239CrossRefGoogle Scholar
  27. Sacco AG, Subramanian MG, Yurewicz EC, De Mayo FJ, Dukelow WR (1983) Heteroimmunization of squirrel monkeys (Saimiri sciureus) with a purified porcine zona antigen(PPZA): immune response and biological activity of antiserum. Fertil Steril 29: 350–358Google Scholar
  28. Shahani SM, Kulkarni PP, Patel KL, Salahuddi M, Das C, Talwar GP (1982) Clinical and immunological responses with Pr-I3-hCG-TT vaccine. Contraception 25: 421–434PubMedCrossRefGoogle Scholar
  29. Skinner SM, Mills T, Kirchick HJ, Dunbar BS (1984) Immunization with zona pellucida proteins results in abnormal ovarian follicular differentiation and inhibition of gonadotrophin induced steroid secretion. Endocrinology 115: 2428–2432Google Scholar
  30. Stevens VC, Powell JE, Rickmey M, Lee AC, Lewis DH (1990) Studies of various delivery systems for a human chorionic gonadotrophin vaccine. In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 549Google Scholar
  31. Talwar GP, Singh O, Pal R, Arunan K (1990) Experiences of the anti-hCG vaccine of relevance to development of other birth control vaccines. In: Alexander NJ, Griffin D, Spieler JM, Waites GMH (eds) Gamete interaction: prospects for immunocontraception. Wiley-Liss Inc, New York, p 579Google Scholar
  32. Talwar GP, Singh O, Rao, LV (1988) An improved immunogen for antihuman chorionic gonadotrophin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross reaction with human follicle stimulating hormone and human thyroid stimulating hormone. J Re-prod Immunol 14: 203–212CrossRefGoogle Scholar
  33. Thau RB, Wilson CB, Sundaram K, Phillips D, Donelly T, HalmiNS, Bardin CW (1987) Long-term immunization against the 13-subunit of ovine luteinizing hormone (oLHß) has no effect on pituitary function in rhesus monkeys. Am J. Reprod Immunol Microbiol 15: 92–98Google Scholar
  34. Trouson AO, Shivers CA, McMaster R, Lopata A (1980) Inhibition of sperm binding and fertilization of human ova by antibody to porcine zona pellucida and human sera. Arch Androl: 29–35Google Scholar
  35. Wassarman PM (1988) The zona pellucida: a coat of many colours. Bio Essays 6: 161–166Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • R. John Aitken
  • Margaret Paterson
  • P. Thillai Koothan

There are no affiliations available

Personalised recommendations